X
GO
EDF

11th EDF Programme of Support for Health Security Strengthening for Prevention and Control of Outbreaks of Communicable Diseases in the Caribbean

 

Overall Objective/Impact:

To improve public health of the Caribbean population and the sustainable development of the region

Specific Objective(s)/Outcome(s):

To improve health security in the region, including the detection, surveillance, prevention, control and response to epidemics of Communicable diseases, such as COVID-19.

Expected Results/Outputs:

  1. Increased capacity for detection, monitoring and surveillance of Communicable Diseases, including COVID-19, in the Caribbean;
  2. Increased capacity of CARPHA and CARPHA Member States to respond to and manage outbreaks of COVID-19 and other Communicable diseases;
  3. Strengthened public education and behaviour change programmes on Communicable diseases;
  4. Strengthened regional coordination mechanisms for prevention and response to Communicable diseases;
  5. Institutional capacity of CARPHA strengthened to effectively support the Caribbean in preparing for and responding to public health emergencies

CARPHA Programmatic Area(s):

Status of Implementation:
Ongoing

Start Date:
11th April 2020

End Date:
10th April 2024

Duration:
48 months

Budget:
€8,000,000

Source(s) of Funding:
European Union (EU)

Beneficiary CARPHA Member State(s):
All CARPHA Member States (CMS)

Link to Project Document(s):

Link to Project Events/Activities:

Focal Point(s):
Dr Lisa Indar
Assistant Director, SDPC
Email:indarlis@carpha.org

 

Overview of Project:

The activities proposed under this Action are in response to the pandemic of COVID-19, in the first instance, and thereafter to support CARPHA in its role as the gatekeeper of regional health security, and its mandate to lead the health response to public health emergencies like COVID-19.

Direct/immediate response to COVID-19:

  • Procurement and distribution of Personal Protective Equipment (PPE) to CMS, based on their needs, in response to COVID-19 and other Communicable Diseases
  • Procurement and distribution of vaccines and/or other treatments for COVID-19 to CMS
  • Strengthening diagnostic testing for Communicable Diseases, including COVID-19, at CARPHA and CARPHA Member States through the procurement of test kits, reagents and consumables as well as new equipment
  • Support for management and implementation of quarantine and isolation procedures in CMS and of contact tracing for COVID-19 through capacity building and training
  • Support for and promotion of the use of COVID-19 Guidelines and Protocols among public health professionals in CMS through capacity-building and training
  • Development of two new modules of CR-FELTP:
    1. a virtual infectious disease simulation exercise which health practitioners can utilize to train in the principles of outbreak investigation;
    2. a course for medical practitioners who are on the frontline of dealing with patients

Other interventions to strengthen health systems in the region for health security in the region:

  • Support for the implementation of recommendations of assessments of surveillance systems in the region
  • Strengthening real-time visitor-based syndromic surveillance through the implementation of the Tourism and Health Information System (THiS) in CMS.
  • Support for the implementation of CARPHA’s Biosecurity and Biosafety programme
  • Support for the development and implementation of detailed International Health Regulations (IHR) country readiness and implementation plans using the IHR Joint External Evaluation (JEE) Tool
  • Support for the execution of simulation exercises on responding to public health emergencies
  • Strengthening of risk communication in CARPHA Member States through training in risk communication and the development/revision of country risk communication strategies
  • Support for the conduct of research and/or studies on matters related to regional health security, to strengthen public health interventions to prevent, detect and control COVID-19 and other communicable diseases
  • Support for the institutional strengthening of CARPHA